SAN FRANCISCO, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Zephyr Health today announced its expanded status as a Veeva Web Approved Technology Partner to accelerate sales and marketing effectiveness for pharmaceutical and biotech organizations. Zephyr will integrate Illuminate’s powerful insights and Scores with Veeva CRM Suggestions to help improve customers’ field productivity with unique market and medical context, giving field teams the insights they need to extend and enrich customer interactions, accelerate sales productivity and meet sales targets more confidently.
“Today’s announcement with industry leader Veeva Systems is another solid step in Zephyr Health’s journey to transform the way life sciences companies develop and launch products,” said William King, founder of Zephyr Health. "Unlike tools that focus on CRM data or consulting-centered analytics software, Zephyr Illuminate combines our market-leading, fully-integrated data platform and machine learning with Veeva’s innovative CRM suite - something that will change the game for sales and marketing teams globally.”
“Next-generation commercial excellence takes an ecosystem of partners who are capable of bringing innovation to Life Sciences’ commercial teams,” said Brian Longo, General Manager, Veeva Commercial Products. “The integration of Veeva CRM Suggestions with solutions like Zephyr Illuminate’s Insights-as-a-Service supports our joint customers’ success by giving them greater choice and supporting their imperative to deliver unprecedented customer experience.”
Early this year Zephyr Health announced it joined the Veeva OpenData Partner Program. This new partnership extends that collaboration to bring Zephyr Scores and Recommendations, powered by global disease-area data, proprietary algorithms and data science expertise to Veeva customers.
About Zephyr IlluminateTM
Zephyr Illuminate is the only Insights-as-a-service solution that integrates global health data from thousands of disconnected sources to provide precise and predictive customer and market insights for Life Sciences companies so that they can make confident decisions faster across the entire product lifecycle.
About Zephyr Health
Founded in 2011 by William King, Zephyr Health is the leading insights-as-a-service company harnessing the power of global health data to address critical business and patient needs. From clinical trials to market strategy and sales performance, Zephyr Illuminate™ helps Life Sciences companies make confident decisions faster across the entire product lifecycle with precise and predictive market insights. Zephyr Health's customers include Fortune 100 biopharmaceutical, diagnostic and medical device companies like Amgen, Genentech, Gilead, Medtronic and Onyx.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.